The Rapid Acceleration of Diagnostics Technology (RADx® Tech) Advancing Cures and Therapies and ending ENDOmetriosis diagnostic delays (ACT ENDO) Challenge will award $3.0 million in prizes to accelerate the development of innovative technologies for the diagnosis of endometriosis. Endometriosis is a chronic inflammatory condition characterized by the growth of uterine endometrium-like tissue outside the uterus; the often-debilitating condition affects approximately 1 in 10 reproductive-aged women worldwide. Novel approaches are urgently needed to identify those who are afflicted with the condition and to spur the development of new treatments and cures. Successful technologies developed in this Challenge will shorten the time to diagnosis, eliminate the invasiveness of current techniques, and/or improve accessibility, safety, convenience, and costs of diagnosis. Examples of desired technologies include, but are not limited to, imaging technologies, in vitro diagnostic devices, clinical laboratory tests, wearable devices, smartphone-enabled diagnostic tools, integrated sensing technologies, and digital health platforms.
Learn more about the challenge online here and during this webinar event.
Register Now
